| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 检测设备及试剂(元) | 47,344,591.59 | 87,842,819.14 | 29,953,432.41 | 121,154,941.13 | 50,273,107.66 |
| 进口白蛋白(元) | - | 3,255,511,977.50 | - | 3,626,557,503.89 | 1,954,885,405.94 |
| 静丙(元) | - | 1,491,135,961.19 | - | 1,698,689,402.21 | 839,022,274.37 |
| 自产白蛋白(元) | - | 1,271,479,949.85 | - | 1,494,060,050.48 | 800,381,182.16 |
| 静注射人免疫球蛋白(元) | 673,921,216.34 | - | 721,716,268.38 | - | - |
| 其中:进口白蛋白(元) | 1,435,441,503.61 | - | 1,899,143,417.99 | - | - |
| 其中:自产白蛋白(元) | 483,258,518.79 | - | 678,878,983.36 | - | - |
| 其他血液制品(元) | 567,963,663.64 | 1,233,779,558.92 | 621,406,664.75 | 1,233,152,408.91 | 606,819,928.40 |
| 营业成本(元) | |||||
| 检测设备及试剂(元) | 39,987,228.40 | 66,076,002.60 | 19,572,873.43 | 78,125,197.87 | 30,007,561.55 |
| 进口白蛋白(元) | - | 2,764,779,475.45 | - | 3,023,870,814.68 | 1,605,828,494.05 |
| 静丙(元) | - | 681,051,311.15 | - | 709,654,996.77 | 346,227,501.25 |
| 自产白蛋白(元) | - | 788,454,470.46 | - | 826,320,672.11 | 430,561,271.36 |
| 静注射人免疫球蛋白(元) | 343,350,346.58 | - | 310,040,538.67 | - | - |
| 其中:进口白蛋白(元) | 1,208,137,302.28 | - | 1,582,598,046.08 | - | - |
| 其中:自产白蛋白(元) | 341,691,347.61 | - | 413,497,653.70 | - | - |
| 其他血液制品(元) | 149,663,241.90 | 300,589,013.24 | 135,050,472.61 | 218,891,542.45 | 101,251,367.14 |
| 毛利(元) | |||||
| 检测设备及试剂(元) | 7,357,363.19 | 21,766,816.54 | 10,380,558.98 | 43,029,743.26 | 20,265,546.11 |
| 进口白蛋白(元) | - | 490,732,502.05 | - | 602,686,689.21 | 349,056,911.89 |
| 静丙(元) | - | 810,084,650.04 | - | 989,034,405.44 | 492,794,773.12 |
| 自产白蛋白(元) | - | 483,025,479.39 | - | 667,739,378.37 | 369,819,910.80 |
| 静注射人免疫球蛋白(元) | 330,570,869.76 | - | 411,675,729.71 | - | - |
| 其中:进口白蛋白(元) | 227,304,201.33 | - | 316,545,371.91 | - | - |
| 其中:自产白蛋白(元) | 141,567,171.18 | - | 265,381,329.66 | - | - |
| 其他血液制品(元) | 418,300,421.74 | 933,190,545.68 | 486,356,192.14 | 1,014,260,866.46 | 505,568,561.26 |
| 毛利率(%) | |||||
| 检测设备及试剂(%) | 15.54 | 24.78 | 34.66 | 35.52 | 40.31 |
| 进口白蛋白(%) | - | 15.07 | - | 16.62 | 17.86 |
| 静丙(%) | - | 54.33 | - | 58.22 | 58.73 |
| 自产白蛋白(%) | - | 37.99 | - | 44.69 | 46.21 |
| 静注射人免疫球蛋白(%) | 49.05 | - | 57.04 | - | - |
| 其中:进口白蛋白(%) | 15.84 | - | 16.67 | - | - |
| 其中:自产白蛋白(%) | 29.29 | - | 39.09 | - | - |
| 其他血液制品(%) | 73.65 | 75.64 | 78.27 | 82.25 | 83.31 |
| 收入构成(%) | |||||
| 检测设备及试剂(%) | 1.48 | 1.20 | 0.76 | 1.48 | 1.18 |
| 进口白蛋白(%) | - | 44.35 | - | 44.37 | 45.98 |
| 静丙(%) | - | 20.32 | - | 20.78 | 19.74 |
| 自产白蛋白(%) | - | 17.32 | - | 18.28 | 18.83 |
| 静注射人免疫球蛋白(%) | 21.01 | - | 18.27 | - | - |
| 其中:进口白蛋白(%) | 44.75 | - | 48.07 | - | - |
| 其中:自产白蛋白(%) | 15.06 | - | 17.18 | - | - |
| 其他血液制品(%) | 17.70 | 16.81 | 15.73 | 15.09 | 14.27 |
| 毛利构成(%) | |||||
| 检测设备及试剂(%) | 0.65 | 0.79 | 0.70 | 1.30 | 1.17 |
| 进口白蛋白(%) | - | 17.92 | - | 18.17 | 20.09 |
| 静丙(%) | - | 29.58 | - | 29.82 | 28.36 |
| 自产白蛋白(%) | - | 17.64 | - | 20.13 | 21.28 |
| 静注射人免疫球蛋白(%) | 29.38 | - | 27.62 | - | - |
| 其中:进口白蛋白(%) | 20.20 | - | 21.24 | - | - |
| 其中:自产白蛋白(%) | 12.58 | - | 17.81 | - | - |
| 其他血液制品(%) | 37.18 | 34.07 | 32.63 | 30.58 | 29.10 |